-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UYYKweCdoWDfg4m1HNF10OIY79p7GQ2lG/f5d77jRLhwTuVn7u1qkCcgQ+xTQfWi YHOmkERrv5OydFC5n8Rh9w== 0001033409-07-000017.txt : 20070502 0001033409-07-000017.hdr.sgml : 20070502 20070502142837 ACCESSION NUMBER: 0001033409-07-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070501 FILED AS OF DATE: 20070502 DATE AS OF CHANGE: 20070502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 07809969 BUSINESS ADDRESS: BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 3151 17TH STREET EXTENSION CITY: WILMINGTON STATE: NC ZIP: 28412 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-05-01 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001033409 ESHELMAN FREDRIC N 6814 TOWLES ROAD WILMINGTON NC 28409 1 1 0 0 CEO Common Stock 2007-05-01 4 S 0 100 35.36 D 8768094 D Common Stock 2007-05-01 4 S 0 100 34.46 D 8767994 D Common Stock 2007-05-01 4 S 0 100 35.51 D 8767894 D Common Stock 2007-05-01 4 S 0 100 35.62 D 8767794 D Common Stock 2007-05-01 4 S 0 200 35.63 D 8767594 D Common Stock 2007-05-01 4 S 0 100 35.71 D 8767494 D Common Stock 2007-05-01 4 S 0 200 35.89 D 8767294 D This Form 4 is 3 of 3 Forms 4 being filed to report the sale of stock on May 1, 2007 pursuant to the 10b5-1 trading plan adopted by the Reporting Person. Lisa C. Noecker attorney-in-fact for Fred N. Eshelman 2007-05-02 -----END PRIVACY-ENHANCED MESSAGE-----